BioSpace News Archive

SELLAS Life Sciences Group, Inc. today announced that the first patient has been dosed in a Phase 2a study of its novel and highly selective CDK9 inhibitor, GFH009, in combination with venetoclax and azacitidine (aza/ven) in patients with relapsed/refractory (r/r) acute myeloid leukemia (AML) who did not respond or stopped responding to venetoclax-based therapies.

Cancer and cardiovascular diseases (CVDs) continue to be two of the biggest challenges facing modern medicine.

Accumulus Synergy, a nonprofit trade association working to address the global need for digital transformation within the life sciences - regulatory ecosystem, announced the appointment of Jacques Mascaro as the new Chair of the Board of Directors.

Evolus, Inc. today announced the completion of its Phase 2 clinical study evaluating an “extra-strength” dose for extended duration of Jeuveau ® (prabotulinumtoxinA-xvfs).

Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery company developing novel, optimized, next-generation psychedelic and non-psychedelic medications to treat neuropsychiatric and neurological disorders with unmet medical needs,

NVision Imaging, a developer of MRI polarizers and hyperpolarized imaging agents, announced that they have closed a $30M Series A round, with an additional $19.5M in funding from the German government.

Hospital for Special Surgery announced its phased leadership transition will be completed on September 5, when Bryan T. Kelly, MD, MBA succeeds Louis A. Shapiro as CEO.

Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”), announced that effective today, Edward J. Borkowski, former Chief Financial Officer of Mylan N.V, has been appointed to the Company’s Board of Directors.

BIO International Convention is the world’s largest international biotech industry exhibition and forum organized by the Biotechnology Industry Organization in the U.S. every year.

Huntsman Cancer Institute at the University of Utah, a pioneering innovator dedicated to developing more effective ways to care for and prevent cancer, announced plans for a new Huntsman Cancer Institute comprehensive cancer center in Utah County.